The cost-effectiveness of mechanical forms of DVT prophylaxis in general surgery

被引:0
|
作者
Ramaswami, G
Nicolaides, AN
机构
关键词
deep venous thrombosis; intermittent pneumatic; compression;
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Graduated elastic compression (GEC) and intermittent pneumatic compression (IPC) are physical methods used for the prevention of deep venous thrombosis (DVT). To determine if this prevention is cost-effective, we reviewed the literature to identify the number of thromboembolic events prevented by current prophylaxis, and the cost associated with these events, as well as their avoidance with prophylaxis. In 6 studies, GEC stockings were shown to produce a 64% reduction in DVT in patients undergoing general surgery. The mean incidence of DVT in 525 unprophylaxed patients was 22.5% and in the treatment group 8.2% (95% CI 2.7-13.7). IPC has been shown to produce a 74% reduction in the incidence of post-operative DVT in 11 studies (general surgery). The mean incidence of DVT in 665 patients in the control group was 26% and in the treatment group 6.8% (95% CI 4.8-8.8). Based on the efficacy and risk reduction that DVT prophylaxis provides, the total cost-effectiveness of prophylaxis was calculated per 1000 patients. The cost of no prophylaxis in general surgery was pound 23,300. The cost of various methods of prophylaxis, including pharmacological as well as mechanical modalities, plus the cost of treating the few DVT that become clinically manifest despite prophylaxis is less expensive than that of using no prophylaxis at all. GEC stockings are cost-effective in low-risk surgical patients and can be used in combination with other methods of prevention in moderate and high risk surgical patients. IPC is also a cost-effective modality of prophylaxis in general surgery. We conclude that mechanical prophylaxis provides the most cost-effective method for preventing DVT in patients undergoing low and moderate risk surgery.
引用
收藏
页码:21 / 26
页数:6
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF VENOUS THROMBOEMBOLISM PROPHYLAXIS IN SURGERY
    BERGQVIST, D
    EUROPEAN JOURNAL OF SURGERY, 1994, : 49 - 53
  • [2] MEASURING THE COST-EFFECTIVENESS OF ANTIBIOTIC-PROPHYLAXIS IN SURGERY
    DAVEY, P
    MALEK, M
    THOMAS, P
    AMERICAN JOURNAL OF SURGERY, 1992, 164 (4A): : S39 - S43
  • [3] Cost-effectiveness of combination thromboembolism prophylaxis in gynecologic oncology surgery
    Dainty, L
    Maxwell, GL
    Clarke-Pearson, DL
    Myers, ER
    GYNECOLOGIC ONCOLOGY, 2004, 93 (02) : 366 - 373
  • [4] COST-EFFECTIVENESS OF ANTIBIOTIC PROPHYLAXIS
    Friedlander, Arthur H.
    Chang, Tina I.
    Aghazadehsanai, Nona
    Graves, Lindsay L.
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2016, 147 (04): : 229 - 230
  • [5] COST-EFFECTIVENESS OF MINOR SURGERY IN GENERAL-PRACTICE
    STAINFORTH, J
    GOODFIELD, MJD
    BRITISH JOURNAL OF GENERAL PRACTICE, 1992, 42 (360): : 302 - 303
  • [6] PREVENTION OF VENOUS THROMBOEMBOLISM AFTER GENERAL-SURGERY - COST-EFFECTIVENESS ANALYSIS OF ALTERNATIVE APPROACHES TO PROPHYLAXIS
    OSTER, G
    TUDEN, RL
    COLDITZ, GA
    AMERICAN JOURNAL OF MEDICINE, 1987, 82 (05): : 889 - 899
  • [7] DVT Prophylaxis in General Surgery - Are We Doing It Right?
    O'Flanagan, C.
    Aremu, M.
    Soomro, N.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2019, 188 : S45 - S46
  • [8] DVT Surveillance Program in the ICU: Analysis of Cost-Effectiveness
    Malhotra, Ajai K.
    Goldberg, Stephanie R.
    McLay, Laura
    Martin, Nancy R.
    Wolfe, Luke G.
    Levy, Mark M.
    Khiatani, Vishal
    Borchers, Todd C.
    Duane, Therese M.
    Aboutanos, Michel B.
    Ivatury, Rao R.
    PLOS ONE, 2014, 9 (09):
  • [9] Cost-effectiveness of deep venous thrombosis prophylaxis in gynecologic oncology surgery
    Maxwell, GL
    Myers, ER
    Clarke-Pearson, DL
    OBSTETRICS AND GYNECOLOGY, 2000, 95 (02): : 206 - 214
  • [10] Cost-effectiveness of amiodarone for prophylaxis of atrial fibrillation after cardiothoracic surgery
    Gillespie, EL
    White, M
    Kluger, J
    Rancourt, JA
    Gallagher, R
    Coleman, CI
    PHARMACOTHERAPY, 2006, 26 (04): : 499 - 504